Amedica (AMDA) delayed the filing of its Quarterly Report on Form 10-Q for 1Q17, and received a listing non-compliance notice from NASDAQ. The notification letter has no immediate effect on the listing of AMDA’s common stock on NASDAQ.
The company requires additional time to consider potential impairment related to certain long-lived assets in connection with the completion of the audit of its 2016 financial results, and the filing of its Annual Report on Form 10-K. AMDA expects to promptly file its Form 10-Q upon filing its Annual Report.
The company has until June 19 to submit a compliance plan to NASDAQ. If unable to file Form 10-K and Form 10-Q by that time, AMDA will submit a compliance plan on or before June 19. If the plan is accepted, NASDAQ can grant an exception of up to 180 calendar days from the filing’s due date, or until September 27, to regain compliance. If NASDAQ doesn’t accept the plan, AMDA can appeal the decision.
Sources: Amedica Corporation; ORTHOWORLD Inc.
Amedica (AMDA) delayed the filing of its Quarterly Report on Form 10-Q for 1Q17, and received a listing non-compliance notice from NASDAQ. The notification letter has no immediate effect on the listing of AMDA's common stock on NASDAQ.
The company requires additional time to consider potential impairment related to certain long-lived assets in...
Amedica (AMDA) delayed the filing of its Quarterly Report on Form 10-Q for 1Q17, and received a listing non-compliance notice from NASDAQ. The notification letter has no immediate effect on the listing of AMDA’s common stock on NASDAQ.
The company requires additional time to consider potential impairment related to certain long-lived assets in connection with the completion of the audit of its 2016 financial results, and the filing of its Annual Report on Form 10-K. AMDA expects to promptly file its Form 10-Q upon filing its Annual Report.
The company has until June 19 to submit a compliance plan to NASDAQ. If unable to file Form 10-K and Form 10-Q by that time, AMDA will submit a compliance plan on or before June 19. If the plan is accepted, NASDAQ can grant an exception of up to 180 calendar days from the filing’s due date, or until September 27, to regain compliance. If NASDAQ doesn’t accept the plan, AMDA can appeal the decision.
Sources: Amedica Corporation; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.